Nasdaq has suspended the quotation of Sontra Medical Corp.’s common stock in connection with a previous announcement that Sontra will voluntarily delist from the Nasdaq Capital Market.
Franklin-based Sontra will still remain subject to Nasdaq rules until its delisting is effective on January 18, 2006. As of January 8, the company’s quotation for common stock will appear in the “Pink Sheets” under the symbol “SONT.” Following its delisting from Nasdaq, Sontra anticipates remaining a public company and making its required SEC filings.
Sontra Medical Corp. is developing a non-invasive glucose monitor for use in the Intensive Care market. To read more about the company, click here: Sontra delists, then gets $600k cash injection
